Leonhard Müllauer
Researcher Next ID · RN-040268
Researcher · Biochemistry, Genetics and Molecular Biology
Vienna, Austria
- Works count
- 474
- Citation count
- 10,156
- H-index
- 51
- i10-index
- 165
Research interests
Publications
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
Cancer Discovery · 2021 · 10.1158/2159-8290.cd-21-0538
SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
Molecular Cancer · 2017 · 10.1186/s12943-016-0568-5
Review of cancer treatment with immune checkpoint inhibitors
Wiener klinische Wochenschrift · 2017 · 10.1007/s00508-017-1285-9
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study
The Lancet Haematology · 2017 · 10.1016/s2352-3026(17)30208-9
Molecular pathology of lung cancer: current status and perspectives
Current Opinion in Oncology · 2017 · 10.1097/cco.0000000000000429
Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients
Clinical Cancer Research · 2014 · 10.1158/1078-0432.ccr-13-3355
B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ
Blood · 2013 · 10.1182/blood-2012-10-460741
Masked polycythemia Vera (mPV): Results of an international study
American Journal of Hematology · 2013 · 10.1002/ajh.23585
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Leukemia · 2013 · https://doi.org/10.1038/leu.2013.163
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome
Blood · 2012 · 10.1182/blood-2011-11-393819
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
Blood · 2012 · 10.1182/blood-2012-01-403279
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
Blood · 2012 · 10.1182/blood-2012-06-429597
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)
Oncotarget · 2012 · 10.18632/oncotarget.733
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study
Haematologica · 2012 · 10.3324/haematol.2012.065664
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
Blood · 2011 · 10.1182/blood-2010-07-293761
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.34.5298
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis
Modern Pathology · 2010 · 10.1038/modpathol.2010.224
Mucosa-Associated Lymphoid Tissue Lymphoma: Novel Translocations Including Rearrangements of ODZ2, JMJD2C, and CNN3
Clinical Cancer Research · 2008 · 10.1158/1078-0432.ccr-08-0702
Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells
Cancer Research · 2008 · 10.1158/0008-5472.can-07-2531
Diagnostic and Subdiagnostic Accumulation of Mast Cells in the Bone Marrow of Patients with Anaphylaxis: Monoclonal Mast Cell Activation Syndrome
International Archives of Allergy and Immunology · 2006 · 10.1159/000096442
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites
Leukemia · 2004 · https://doi.org/10.1038/sj.leu.2403501
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis
Annals of Hematology · 2002 · 10.1007/s00277-001-0412-9
Mutations in apoptosis genes: a pathogenetic factor for human disease
Mutation Research/Reviews in Mutation Research · 2001 · 10.1016/s1383-5742(01)00057-6
Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression
Hepatology · 1997 · 10.1002/hep.510250420
Gelsolin: a candidate for suppressor of human bladder cancer.
PubMed · 1995
Current projects
No projects listed.